Treatment of advanced pancreatic cancer with epirubicin, 5-fluorouracil and 1-leucovorin: a phase II study.

[1]  W. Scheithauer,et al.  Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  T. Linné,et al.  Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  J. Robertson,et al.  A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma , 1996, Cancer.

[4]  J. Lotz,et al.  Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  E. Casper,et al.  Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Arbuck.  Overview of chemotherapy for pancreatic cancer , 1990, International journal of pancreatology : official journal of the International Association of Pancreatology.

[7]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .

[8]  F. Mícek.  [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.